{"id":49397,"date":"2018-09-18T01:00:00","date_gmt":"2018-09-26T01:58:03","guid":{"rendered":"http:\/\/www.05921.net\/index.php\/2018\/09\/26\/%e8%8d%af%e7%89%a9%e7%a0%94%e5%8f%91%e6%96%b0%e6%97%b6%e4%bb%a3%ef%bc%9a%e6%95%b0%e6%8d%ae%ef%bc%8c%e9%a2%84%e6%b5%8b%ef%bc%8c%e4%ba%ba%e5%b7%a5%e6%99%ba%e8%83%bd%e6%9a%a8%e7%ac%ac\/"},"modified":"2018-09-26T09:58:07","modified_gmt":"2018-09-26T01:58:07","slug":"%e8%8d%af%e7%89%a9%e7%a0%94%e5%8f%91%e6%96%b0%e6%97%b6%e4%bb%a3%ef%bc%9a%e6%95%b0%e6%8d%ae%ef%bc%8c%e9%a2%84%e6%b5%8b%ef%bc%8c%e4%ba%ba%e5%b7%a5%e6%99%ba%e8%83%bd%e6%9a%a8%e7%ac%ac","status":"publish","type":"post","link":"https:\/\/www.05921.net\/index.php\/49397\/","title":{"rendered":"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n
\n

\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b<\/span><\/strong><\/span>\u5c06\u4e8e<\/span>2018\u5e7410\u670815\u65e5\u5728\u4e0a\u6d77<\/strong><\/span>\u9686\u91cd\u4e3e\u884c\u3002\u76ee\u524d\u8bba\u575b\u524d\u671f\u51c6\u5907\u5de5\u4f5c\u57fa\u672c\u5c31\u7eea\uff0c\u6211\u4eec\u66f4\u65b0\u4e86\u6f14\u8bb2\u5609\u5bbe\u4ecb\u7ecd\u548c\u4f1a\u8bae\u65e5\u7a0b\uff0c\u5728\u6b64\u5411\u60a8\u53d1\u51fa\u7b2c\u4e8c\u8f6e\u9080\u8bf7\u3002<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n
\n
<\/section>\n
\n

\u4f1a\u8bae\u7ec4\u7ec7\u5355\u4f4d<\/span><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\u4e3b\u529e\u65b9<\/span><\/strong><\/span><\/p>\n


<\/span><\/strong><\/p>\n

\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/p>\n


<\/span><\/p>\n

\u8054\u5408\u4e3b\u529e\u65b9<\/span><\/strong><\/span><\/p>\n


<\/span><\/p>\n

\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/p>\n


<\/p>\n

\u5a92\u4f53\u5408\u4f5c\u4f19\u4f34<\/span><\/strong><\/span><\/p>\n


<\/span><\/p>\n

\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/p>\n


<\/p>\n

\n
\n
\n
\n
\n
\n
\n
<\/section>\n
\n

\u8bba\u575b\u6f14\u8bb2\u5609\u5bbe\u4ecb\u7ecd<\/span><\/strong><\/span><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n
<\/section>\n
<\/section>\n
<\/section>\n
\n

Professor Mark Waller, Physics Department, College of Science, Shanghai University<\/span><\/strong><\/span><\/p>\n

Mark Waller\u6559\u6388\uff0c\u4e0a\u6d77\u5927\u5b66\u6559\u6388\uff0c\u7269\u7406\u7cfb\u4e1c\u65b9\u5b66\u8005<\/span><\/strong><\/p>\n

\u25bc<\/span><\/strong><\/span><\/p>\n

\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/p>\n


<\/p>\n

Professor Mark Waller has 45 scientific publications including Nature, Angewandte Chemie, ACS Central Science, and Chemistry – A European Journal, and over 25 oral presentations in academia and industry. Recently Professor Mark Waller and his team has published in Nature the article of \u201cPlanning chemical syntheses with deep neural networks and symbolic AI\u201d (Nature, 555(7698):604-610).  <\/span><\/p>\n


<\/span><\/p>\n

\n
\n
\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

Dr.Rujian Ma,VP & Chief Chemist,head of Chemical Technology Department, New Drug Development Division of WuXi AppTec<\/strong><\/span><\/p>\n

\u9a6c\u6c5d\u5efa\u535a\u58eb\uff0c\u526f\u603b\u88c1\uff0c\u9996\u5e2d\u5316\u5b66\u5bb6\uff0c\u5316\u5b66\u6280\u672f\u90e8\u8d1f\u8d23\u4eba\uff0c\u836f\u660e\u5eb7\u5fb7\u65b0\u836f\u5f00\u53d1\u6709\u9650\u516c\u53f8<\/span><\/strong><\/span><\/p>\n

\u25bc<\/span><\/strong><\/span><\/p>\n

\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/p>\n


<\/p>\n

Dr. Rujian MA received his master’s degree inorganic chemistry from the Department of Chemistry, East China University of Science and Technology in 1995. He returned to China after obtaining doctor\u2019s degree from Japan, and had joint Wuxi Apptec as one of the earliest researchers in the year 2001. In August 2008, Dr. MA was promoted to Vice President of Chemistry. In March 2018, he was appointed chief chemist to lead the Department of chemical technology. Dr. Ma has strong experience in industrial practical organic synthetic chemistry, especially in the design of organic <\/span>synthetic routes.<\/span><\/p>\n


<\/p>\n

\n
\n
\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

Ms. Xing Li, CEO, Deep Intelligent Pharma<\/strong><\/span><\/p>\n

\u674e\u661f\u5973\u58eb\uff0c\u6df1\u5ea6\u667a\u8000 \u9996\u5e2d\u6267\u884c\u5b98<\/span><\/strong><\/span><\/p>\n

\u25bc<\/span><\/p>\n

\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/p>\n


<\/p>\n

Ms. Xing Li is the founder and CEO of Deep Intelligent Pharma. She has worked in the new drug development department of Pfizer, Sanofi, Johnson & Johnson for 12 years with rich experiences. In October 2017, she launched Deep Intelligent Pharma, which aims to empower the entire process of new drug development with state-of-the-art AI technology. Ms. Xing Li had obtained her master’s degree in pharmacy from Peking University.<\/span><\/p>\n


<\/span><\/p>\n

\n
\n
\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

Mr.Gordon Zhang, Sr. Knowledge Management Manager, Novartis<\/strong><\/span><\/p>\n

\u5f20\u6b4c\u5148\u751f\uff0c\u8bfa\u534e\uff08\u4e2d\u56fd\uff09\u751f\u7269\u533b\u5b66\u7814\u7a76\u4e2d\u5fc3 \u9ad8\u7ea7\u7ecf\u7406<\/span><\/strong><\/span><\/p>\n

\u25bc<\/span><\/p>\n

\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/p>\n


<\/p>\n

Representing Novartis Knowledge Center (NKC) in Asia from 2010, Mr. Zhang is in charge of supporting Novartis\u2019s internal colleagues\u2019 needs on external intelligence,particularly focusing on providing decision-making reference & report for leadership team. Mr. Zhang has graduated from Fudan University with a MBA degree from the BI-Fudan MBA program and Jilin University with a bachelor degree majored in Chemistry.<\/span><\/p>\n


<\/span><\/p>\n

\n
\n
\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

Dr. Pierre Morieux,ChemDraw Global Marketing Manager, Perkin Elmer<\/strong><\/span><\/p>\n

Pierre Morieux\u535a\u58eb\uff0cChemDraw\u5168\u7403\u5e02\u573a\u7ecf\u7406\uff0c\u73c0\u91d1\u57c3\u5c14\u9ed8<\/span><\/strong><\/span><\/p>\n

\u25bc<\/span><\/strong><\/span><\/p>\n

\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/p>\n


<\/p>\n

Pierre Morieux got a Ph.D. in Pharmaceutical Sciences in 2010 from the University of North Carolina at Chapel Hill, and then did a post-doc in bioorganic chemistry at the University of Strasbourg, France. After 4 years spent as a Field Application Scientist, he is now the ChemDraw Global Marketing Manager at PerkinElmer.<\/span><\/p>\n


<\/span><\/p>\n

\n
\n
\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

Dr. Guozhi Tang, VP of Discovery, Ascentage Pharma<\/strong><\/span><\/p>\n

\u5510\u56fd\u5fd7\u535a\u58eb\uff0c\u836f\u7269\u53d1\u73b0\u526f\u603b\u7ecf\u7406\uff0c\u4e9a\u76db\u533b\u836f<\/span><\/strong><\/span><\/p>\n

\u25bc<\/span><\/strong><\/span><\/p>\n

\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/p>\n


<\/p>\n

Dr. Guozhi Tang joined Ascentage Pharma in 2016 as VP of Discovery to take care of the early stage portfolio and discovery. Prior to that, he was a principle scientist and research investigator at Roche Innovation Center Shanghai (RICS), where he had led various discovery projects to success delivery of 4+ preclinical candidates and clinical-stage drugs in anti-cancer,anti-viral and metabolic disease areas. Gordon has 30+ publications and 12+patents, and he serves as a SAB member of J. Med. Chem.<\/span><\/p>\n


<\/span><\/p>\n

\n
\n
\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

Mr. NealKatz, Elsevier Life Science Solution Marketing Director<\/strong><\/span><\/p>\n

Neal Katz\u5148\u751f\uff0c\u751f\u547d\u79d1\u5b66\u89e3\u51b3\u65b9\u6848\u5e02\u573a\u603b\u76d1\uff0c\u7231\u601d\u552f\u5c14<\/span><\/strong><\/span><\/p>\n

\u25bc<\/span><\/p>\n

\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/p>\n


<\/p>\n

Neal Katz has spent over 20 years focusing on B2B IT solutions in the communications, academic and pharmaceutical industries.  He has launched and managed business solutions at several companies including AT&T, Global Crossing, and Intel. Nealjoint Elsevier in 2008. In 2017, he became the Director of Life Science Solutions Marketing. Neal lives in Bridgewater, NJ and has an MBA from the City University of New York.<\/span><\/p>\n


<\/span><\/p>\n

\n
\n
\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

Dr.Matthew Clark, Director, Scientific Services, Elsevier<\/strong><\/span><\/p>\n

Matthew Clark\u535a\u58eb,\u79d1\u5b66\u670d\u52a1\u603b\u76d1\uff0c\u7231\u601d\u552f\u5c14<\/span><\/strong><\/span><\/p>\n

\u25bc<\/span><\/p>\n

\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/p>\n


<\/p>\n

Dr.Matthew Clark is Director of Scientific Services at Elsevier. He has broad experience in pharmaceutical research and development. He has led teams in discovery research in large and small pharmaceutical companies, and in the scientific software and data industries. He is highly published in preclinicaland clinical informatics for pharmaceutical development. Dr. Clark\u2019s team at Elsevier work with leading pharmaceutical companies applying AI\/Machine Learning to synthetic chemistry, predictive modeling, and safety pharmacology.<\/span><\/p>\n


<\/span><\/p>\n

\n
\n
\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

Mr. Genan Zhao, General Manager, Research Solutions, Elsevier China<\/strong><\/span><\/p>\n

\u8d75\u6b4c\u5583\u5148\u751f,\u4e2d\u56fd\u533a\u79d1\u6280\u90e8\u603b\u7ecf\u7406\uff0c\u7231\u601d\u552f\u5c14<\/span><\/strong><\/span><\/p>\n

\u25bc<\/span><\/p>\n

\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/p>\n


<\/p>\n

Genan Zhao is the General Manager of Elsevier\u2019s Research Solutions in China. In his over 20 years in the technology industry, including 15 years at Microsoft, he has been responsible for multiple successful initiatives including product research and development, customer services. He has considerate expertise in assisting corporations in their transition to digital operations. Genan rounds out our panel with a perspective on the informatics technologies that enable modern chemical sciences research.<\/span><\/p>\n<\/section>\n

<\/section>\n
\n
<\/section>\n<\/section>\n
\n
<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n
\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n
\n
<\/section>\n
\n

\u8bba\u575b\u5730\u70b9<\/span><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n

\u4e0a\u6d77\u535a\u96c5\u9152\u5e97\uff08\u5f20\u6c5f\u9ad8\u79d1\uff09\uff0c\u78a7\u6ce2\u8def699\u53f7<\/span><\/strong>
<\/p>\n<\/section>\n<\/section>\n<\/section>\n

\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/p>\n


<\/p>\n

\n
\n
\n
\n
\n
\n
\n
<\/section>\n
\n

\u8bba\u575b\u65e5\u7a0b\u5b89\u6392<\/span><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
<\/section>\n<\/section>\n
<\/section>\n<\/section>\n<\/section>\n<\/section>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

\u65f6\u95f4<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

\u4e3b\u9898<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

\u6f14\u8bb2\u4eba<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n

8:30-9:00<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Registration <\/p>\n

\u7b7e\u5230<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n

9:00-9:10<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Opening <\/span><\/p>\n

\u5f00\u5e55\u81f4\u8f9e<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Mr. Genan ZHAO, General Manager, Research Solutions, Elsevier China<\/span><\/p>\n

\u8d75\u6b4c\u5583\u5148\u751f, \u7231\u601d\u552f\u5c14\u4e2d\u56fd\u533a\u79d1\u6280\u90e8\u603b\u7ecf\u7406<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n

9:10-9:50<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Learning the Art of Chemical Synthesis with Discipline Scale Data<\/p>\n

\u5229\u7528\u5b66\u79d1\u5927\u6570\u636e\u63a2\u7d22\u5316\u5b66\u5408\u6210\u4e4b\u7f8e<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Professor Mark Waller, Shanghai University<\/p>\n

Mark Waller \u6559\u6388\uff0c\u4e0a\u6d77\u5927\u5b66<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n

9:50-10:30<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Present Situation and the Prospect of Computer Aided Drug Design<\/span><\/p>\n

\u8ba1\u7b97\u673a\u8f85\u52a9\u6709\u673a\u5408\u6210\u8def\u7ebf\u8bbe\u8ba1\u73b0\u72b6\u4e0e\u5c55\u671b<\/span><\/p>\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Dr. Rujian MA, VP & Chief Chemist, Head of Chemical Technology Department, New Drug Development Division of WuXi AppTec <\/span><\/p>\n

\u9a6c\u6c5d\u5efa\u535a\u58eb\uff0c\u836f\u660e\u5eb7\u5fb7\u65b0\u836f\u5f00\u53d1\u6709\u9650\u516c\u53f8 \u526f\u603b\u88c1\uff0c\u9996\u5e2d\u5316\u5b66\u5bb6\uff0c\u5316\u5b66\u6280\u672f\u90e8\u8d1f\u8d23\u4eba<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n

10:30-10:45<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Q&A Discussion<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n
\n
\n
\n

10:45-11:00<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Tea Break  \u8336\u6b47<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n

11:00-11:40<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

AI Accelerates New Drug Research and Development<\/span><\/p>\n

\u667a\u8000\u65e0\u754c\uff0c\u9886\u822a\u7814\u53d1 \u2013 AI\u52a0\u901f\u65b0\u836f\u7814\u53d1<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Ms. Xing LI, CEO, Deep Intelligent Pharma <\/span><\/p>\n

\u674e\u661f\u5973\u58eb\uff0c\u6df1\u5ea6\u667a\u8000 \u9996\u5e2d\u6267\u884c\u5b98<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n

11:40-12:20<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Turning Big Data into Smart Data: Analytics and the Pharma R&D Ecosystem<\/p>\n

\u5316\u5927\u6570\u636e\u4e3a\u667a\u6570\u636e\uff1a\u5206\u6790\u4e0e\u533b\u836f\u7814\u53d1\u751f\u6001\u7cfb\u7edf<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Mr. Neal Katz, Life Science Solution Mktg Director, Elsevier<\/p>\n

Neal Katz\uff0c \u7231\u601d\u552f\u5c14\u751f\u547d\u79d1\u5b66\u89e3\u51b3\u65b9\u6848\u5e02\u573a\u603b\u76d1<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n

12:20-12:30<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Q&A Discussion<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n

12:30-13:30<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Lunch   \u5348\u9910<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n
\n
\n
\n

13:30-14:10<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Targeting protein-protein interactions (PPI) in drug discovery: An Ascentage journey<\/p>\n

\u9488\u5bf9\u86cb\u767d-\u86cb\u767d\u76f8\u4e92\u4f5c\u7528\u7684\u836f\u7269\u53d1\u73b0\u2014\u4e9a\u76db\u533b\u836f<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Dr. Guozhi TANG, VP of Discovery, Ascentage Pharma<\/p>\n

\u5510\u56fd\u5fd7\u535a\u58eb\uff0c\u4e9a\u76db\u533b\u836f \u836f\u7269\u53d1\u73b0\u526f\u603b\u7ecf\u7406<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n

14:10-14:50<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

AI in Healthcare<\/span><\/p>\n

\u533b\u7597\u4ea7\u4e1a\u4e2d\u7684\u4eba\u5de5\u667a\u80fd\u5e94\u7528<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Mr. Gordon ZHANG, Sr. Knowledge Mgt Manager, Novartis<\/span><\/p>\n

\u5f20\u6b4c\u5148\u751f\uff0c\u8bfa\u534e\uff08\u4e2d\u56fd\uff09\u751f\u7269\u533b\u5b66\u7814\u7a76\u4e2d\u5fc3 \u9ad8\u7ea7\u7ecf\u7406<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n

14:50-15:10<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Beyond Chemical Drawing: ChemDraw 18 featuring Elsevier Reaxys.<\/p>\n

\u8d85\u8d8a\u5316\u5b66\u7ed3\u6784\u7ed8\u5236\uff1aChemDraw 18\u4ecb\u7ecd<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Dr. Pierre Morieux, ChemDraw Global Mktg Mgr, Perkin Elmer<\/p>\n

Pierre Morieux\u535a\u58eb\uff0c \u73c0\u91d1\u57c3\u5c14\u9ed8\uff0cChemDraw\u5168\u7403\u5e02\u573a\u7ecf\u7406<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n

15:10-15:25<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Q&A Discussion<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n

15:25-15:40<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Tea Break  \u8336\u6b47<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n
\n
\n
\n

15:40-16:20<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Big data analysis of animal-human concordance<\/p>\n

\u5927\u6570\u636e\u89e3\u5bc6\u52a8\u7269\/\u4eba\u7684\u836f\u7269\u6bd2\u7406\u5b66\u4e00\u81f4\u6027\u5206\u6790<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Dr. Matt Clark, Director, Scientific Services, Elsevier<\/p>\n

Matthew Clark\u535a\u58eb, \u7231\u601d\u552f\u5c14 \u79d1\u5b66\u670d\u52a1\u603b\u76d1<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n

16:20-17:20<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Panel Discussion\uff1a<\/span><\/p>\n

\u5706\u684c\u8ba8\u8bba<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Host: Mr. Genan ZHAO, General Manager, Research Solutions, Elsevier China<\/span><\/p>\n

\u4e3b\u6301\u4eba\uff1a \u8d75\u6b4c\u5583\u5148\u751f, \u7231\u601d\u552f\u5c14\u4e2d\u56fd\u533a\u79d1\u6280\u90e8\u603b\u7ecf\u7406<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n

17:20-17:30<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n

Closing \u95ed\u5e55\u81f4\u8f9e<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n


<\/p>\n<\/section>\n

\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n
\n
<\/section>\n
\n

\u62a5\u540d\u65b9\u5f0f<\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n

\u672c\u6b21\u8bba\u575b\u5c06\u4ee5\u9080\u8bf7\u65b9\u5f0f\u62a5\u540d\uff0c\u8bf7\u5c06\u60a8\u7684<\/span>\u201c\u516c\u53f8\u540d\u79f0\u3001\u59d3\u540d\u3001 \u804c\u52a1\u3001 \u8054\u7cfb\u7535\u8bdd\u3001 Email\u201d<\/strong><\/span>\uff0c\u53d1\u9001\u81f3\u4f1a\u52a1\u90ae\u7bb1<\/span>rdconnectevent@elsevier.com<\/span><\/em>\uff0c<\/span>\u4ee5\u4fbf\u6211\u4eec\u7ed9\u60a8\u53d1\u9001\u9080\u8bf7\u51fd\u3002\u540d\u989d\u6709\u9650\uff0c\u656c\u8bf7\u63d0\u524d\u9884\u7ea6\u5e2d\u4f4d\u3002<\/span>
<\/p>\n<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

\u626b\u63cf\u4e0b\u65b9\u4e8c\u7ef4\u7801<\/span><\/strong><\/p>\n

\u8fdb\u5165\u8bba\u575b\u5b98\u7f51<\/span><\/strong><\/p>\n

\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/p>\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\"\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\"<\/section>\n<\/section>\n<\/section>\n
\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
<\/section>\n<\/section>\n
\n
\n
<\/section>\n<\/section>\n<\/section>\n
\n
\n
<\/section>\n<\/section>\n
\n
\n
\n

\u7231\u601d\u552f\u5c14<\/span><\/strong>\u662f\u4e00\u5bb6\u5168\u7403\u4e13\u4e1a\u4ece\u4e8b\u79d1\u5b66\u4e0e\u533b\u5b66\u7684\u4fe1\u606f\u5206\u6790\u516c\u53f8\u3002\u7231\u601d\u552f\u5c14\u7684\u7814\u53d1\u89e3\u51b3\u65b9\u6848\u96c6\u6210\u6570\u636e\u3001\u5206\u6790\u548c\u6280\u672f\uff0c\u5e2e\u52a9\u60a8\u505a\u51fa\u6570\u636e\u9a71\u52a8\u7684\u836f\u7269\u53d1\u73b0\u548c\u5f00\u53d1\u51b3\u7b56\uff0c\u5e76\u7b80\u5316\u836f\u7269\u8b66\u6212\u7684\u6587\u732e\u76d1\u63a7\u3002\u6211\u4eec\u7684\u5236\u836f\u4e0e\u751f\u547d\u79d1\u5b66\u89e3\u51b3\u65b9\u6848\u2014\u2014Reaxys\u3001ScienceDirect\u3001Scopus\u3001Embase\u3001QUOSAPV\u3001PharmaPendium\u548cProfessionalServices\uff0c\u5747\u7531\u7231\u601d\u552f\u5c14\u5728\u6570\u636e\u3001\u79d1\u5b66\u548c\u6280\u672f\u9886\u57df\u7684\u72ec\u7279\u4e14\u6df1\u539a\u4e13\u4e1a\u77e5\u8bc6\u63d0\u4f9b\u652f\u6301\u3002<\/span><\/p>\n<\/section>\n<\/section>\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n
\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
\n
<\/section>\n<\/section>\n<\/section>\n
\n
\n
<\/section>\n<\/section>\n
\n
\n
\n

\u4e9a\u76db\u533b\u836f<\/span><\/strong>\u662f\u4e00\u5bb6\u5168\u7403\u9886\u5148\u7684\u5904\u4e8e\u4e34\u5e8a\u9636\u6bb5\u7684\u65b0\u836f\u7814\u53d1\u4f01\u4e1a\uff0c\u81f4\u529b\u4e8e\u5728\u80bf\u7624\u3001\u4e59\u809d\u53ca\u4e0e\u8870\u8001\u76f8\u5173\u7684\u75be\u75c5\u7b49\u6cbb\u7597\u9886\u57df\u5f00\u53d1\u521b\u65b0\u836f\u7269\u3002\u516c\u53f8\u62e5\u6709\u81ea\u4e3b\u7814\u53d1\u7684\u86cb\u767d-\u86cb\u767d\u76f8\u4e92\u4f5c\u7528\u9776\u5411\u836f\u7269\u8bbe\u8ba1\u5e73\u53f0\u53ca100\u591a\u9879\u56fd\u9645\u53d1\u660e\u4e13\u5229\u3002\u516c\u53f8\u7814\u53d1\u4ea7\u54c1\u7ba1\u7ebf\u4e3b\u8981\u4e13\u6ce8\u7ec6\u80de\u51cb\u4ea1\u8def\u5f84\u5173\u952e\u86cb\u767d\u7684\u6291\u5236\u5242\uff0c\u901a\u8fc7\u6291\u5236BCL-2\u3001IAP\u6216MDM2-p53\u7b49\uff0c\u91cd\u542f\u80bf\u7624\u7ec6\u80de\u7684\u51cb\u4ea1\u7a0b\u5e8f\uff1b\u7b2c\u4e8c\u4ee3\u548c\u7b2c\u4e09\u4ee3\u7684\u9488\u5bf9\u764c\u75c7\u6cbb\u7597\u4e2d\u51fa\u73b0\u7684\u6fc0\u9176\u7a81\u53d8\u4f53\u7684\u6291\u5236\u5242\uff1b\u4e0e\u80bf\u7624\u6cbb\u7597\u6709\u5bc6\u5207\u76f8\u5173\u6027\u7684\u8868\u89c2\u9057\u4f20\u5b66\u9776\u70b9\u7684\u6291\u5236\u5242\u7b49\u3002\u516c\u53f8\u73b0\u67097\u4e2a\u65b0\u836f\u9879\u76ee\u5df2\u8fdb\u5165\u5230\u4e2d\u56fd\u3001\u7f8e\u56fd\u53ca\u6fb3\u5927\u5229\u4e9a\u7684I-II\u671f\u4e34\u5e8a\u5f00\u53d1\u9636\u6bb5\u3002<\/span><\/p>\n<\/section>\n<\/section>\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n
\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
<\/section>\n
\u7acb\u5373\u8fdb\u5165\u4f1a\u8bae\u5b98\u7f51!<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section><\/div>\n","protected":false},"excerpt":{"rendered":"

\u201c\u836f\u7269\u7814\u53d1\u65b0\u65f6\u4ee3\uff1a\u6570\u636e\uff0c\u9884\u6d4b\uff0c\u4eba\u5de5\u667a\u80fd\u201d\u66a8\u7b2c\u56db\u5c4a\u7231\u601d\u552f\u5c14\u836f\u7269\u7814\u53d1\u8bba\u575b\u5c06\u4e8e2018\u5e7410\u670815\u65e5\u5728\u4e0a\u6d77\u9686\u91cd\u4e3e\u884c\u3002 […]<\/p>\n","protected":false},"author":1,"featured_media":49398,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[2],"tags":[],"_links":{"self":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/49397"}],"collection":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/comments?post=49397"}],"version-history":[{"count":1,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/49397\/revisions"}],"predecessor-version":[{"id":49422,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/49397\/revisions\/49422"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/media\/49398"}],"wp:attachment":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/media?parent=49397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/categories?post=49397"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/tags?post=49397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}